Active Low-Carber Forums
Atkins diet and low carb discussion provided free for information only, not as medical advice.
Home Plans Tips Recipes Tools Stories Studies Products
Active Low-Carber Forums
A sugar-free zone


Welcome to the Active Low-Carber Forums.
Support for Atkins diet, Protein Power, Neanderthin (Paleo Diet), CAD/CALP, Dr. Bernstein Diabetes Solution and any other healthy low-carb diet or plan, all are welcome in our lowcarb community. Forget starvation and fad diets -- join the healthy eating crowd! You may register by clicking here, it's free!

Go Back   Active Low-Carber Forums > Main Low-Carb Diets Forums & Support > Low-Carb Studies & Research / Media Watch > LC Research/Media
User Name
Password
FAQ Members Calendar Mark Forums Read Search Gallery My P.L.A.N. Survey


Reply
 
Thread Tools Display Modes
  #1   ^
Old Fri, Jun-15-01, 10:37
tamarian's Avatar
tamarian tamarian is offline
Forum Founder
Posts: 19,570
 
Plan: Atkins/PP/BFL
Stats: 400/223/200 Male 5 ft 11
BF:37%/17%/12%
Progress: 89%
Location: Ottawa, ON
Default DNA Banks: Detect Susceptibility to Obesity

Friday June 15, 7:03 am Eastern Time

Press Release

GeneLink, Inc Announces the Filing of a U.S. Patent Application for a SNPs Based Method to Detect Susceptibility to Obesity

MARGATE, N.J.--(BW HealthWire)--June 15, 2001--GeneLink, Inc. (OTCBB:GNLK - news), The World's First Family Centered DNA Bank and Hereditary Genetic Information Service, today announced that it has filed a U.S. Patent Application through the Philadelphia office of the international law firm of Akin, Gump, Strauss, Hauer & Feld, for GeneLink's new invention of a proprietary method to detect an individual's susceptibility to obesity.

Obesity is a condition that affects at least 70 million Americans, more than one-third of all adults and one in five children. Obesity is considered an important risk factor for the development of diabetes, hypertension and cardiovascular disease. Some people are more susceptible to obesity than others.

Specifically, this genetics based obesity test (Patent Pending) is designed to measure single-nucleotide polymorphisms, or SNPs (pronounced ``snips''), which are small variations in DNA. The test looks for SNPs in several key genes that are associated with obesity.

Obesity increases one's risk of developing conditions such as high blood pressure, diabetes, heart disease, stroke, gall bladder disease and cancer of the breast, prostate and colon. The test provides a score that can be used as a guide to determine what level of intervention or therapy would be helpful to combat or prevent the problems associated with obesity.

An attractive feature of this test is the easy and non-invasive method by which the samples are collected using the patented GeneLink DNA Collection KitŪ. Simply, the DNA material is collected by rubbing the inside of the mouth with swabs, which are then mailed to the testing laboratory. The samples are kept strictly confidential by bar coding. GeneLink has the only patented non-invasive DNA collection system in use today.

Significant opportunities exist for GeneLink to bring to market its proprietary, genetics based obesity test. This test can assist medical, health, anti-aging practitioners; weight loss management companies and nutritional companies offer both an earlier and improved approach to obesity therapies. This assessment test could be a superior solution to those companies seeking to predict their customer's genetic susceptibility to obesity.

``The Company is extremely excited to be able to bring this important new product to the weight management, health and nutritional industries. This assessment could put companies at the leading edge when it comes to developing customized formulations based on their customers genetic profile,'' says John R. DePhillipo, Chairman and CEO of GeneLink, Inc. ``The Obesity Susceptibility test is a major addition to GeneLink's other genetic assessment tests (patents pending), which include assays for estimating susceptibility to oxidative stress (OS) and oxidative stress related to skin aging. We have received an overwhelming response from major weight loss and nutritional companies seeking distribution. It is our belief that revenues from this product will begin by September 1st of this year.''

Forward-Looking Statements: This news release contains certain ``forward-looking statements'' within the meaning of the Private Securities Litigation Reform Act of 1995, which provides a new ``safe harbor'' for these types of statements.

SOURCE: GeneLink, Inc.

http://biz.yahoo.com/bw/010615/2063.html
Reply With Quote
Sponsored Links
  #2   ^
Old Fri, Jun-15-01, 11:17
r.mines's Avatar
r.mines r.mines is offline
Senior Member
Posts: 1,383
 
Plan: Atkins
Stats: 162/124/120 Female 5'1"
BF:
Progress: 90%
Location: Vancouver,BC
Thumbs down Yuck

This kind of stuff is scary. People with the 'obesity gene' (however defined) may be at risk for losing their jobs or not being able to get insurance??? Gee, do the test in utero, and no more fat babies!

I honestly think that there are times when, just because we CAN do something, doesn't mean we SHOULD do it. Unfortunately, the almighty dollar (pound, ruble, etc.) speaks.....

Rachel
who is cowering in a corner
Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Similar Threads
Thread Thread Starter Forum Replies Last Post
What if It's All Been a Big Fat Lie? deelight_99 LC Research/Media 70 Mon, Jul-09-18 07:16
US News: "Rethinking Weight" gotbeer LC Research/Media 4 Tue, Feb-03-04 14:50
Current and Potential Drugs for Treatment of Obesity-Endocrine Reviews Voyajer LC Research/Media 0 Mon, Jul-15-02 18:57
New York Times Atkid LC Research/Media 3 Mon, Jul-08-02 03:05
New York Times article, 7/7/02 destro LC Research/Media 1 Sat, Jul-06-02 17:59


All times are GMT -6. The time now is 06:41.


Copyright © 2000-2024 Active Low-Carber Forums @ forum.lowcarber.org
Powered by: vBulletin, Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.